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phi                  9,l0‐phenanthrenequinone diimine   phzi               benzo[a]phenazine‐5,6‐quinone diimine  PBS                Phosphate Buffered Saline  PCR               Polymerase Chain Reaction  PNA               Peptide Nucleic Acid  ppm               parts per million 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pyr                   pyridine  RNA               Ribonucleic acid  RP‐HPLC      Reverse Phase High Performance Liquid Chromatography  rt                    Room Temperature  RT                  Retention time  s                     singlet (NMR data)   t                      triplet (in NMR data) td                     triple doublet (in NMR data) tpy       2, 2’; 6’,2’’‐terpyridine TFA                 Trifluoroacetic acid  TRISPHAT     tris(tetrachlorobenzenediolato) phosphate(V) tpphz                    tetrapyrido[3,2‐a:2′,3′c:3′′,2′′,‐h:2′′′,3′′′‐j]phenazine)   UV‐vis            Ultraviolet‐visible spectroscopy  vt                      variable temperature  δ                       NMR‐ chemical shift 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Abstract 




 Deoxyribonucleic  acid  (DNA)  contains  all  the  genetic  information  that  codes  for ribonucleic  acid  (RNA)  and  proteins  that  are  essential  for  cell  function.[1]  The mechanism of how cells differentiate does not depend on  the different  information on the DNA contained in each cell but rather on the differences  in how the information is read  or  accessed.  Genetic  information  is  accessed  using  ensembles  of  non‐covalent binding interactions between proteins and DNA sites and leading to the regulation and further  control  of  gene  expression.[1‐3]  DNA  binding  and  recognition  has  been  widely investigated and explored as a means to control gene expression with the careful design of novel agents  that can selectively bind  to DNA allowing  the discovery of new cancer therapeutics and diagnostic devices. 
































































































 There  are  three  different  crystallized  forms  of  double  helix  DNA:  A,  B  and  Z‐DNA (Figure 1.2). 
 




1.2 DNA Recognition   Molecules  can  recognize  DNA  by  both  covalent  and  non‐covalent  interactions.  Five different  modes  in  which  molecules  can  interact  with  B‐DNA  exist.  These  different modes  were  recognized  in  the  60’s:  major  and  minor  groove  binding,  intercalation, sugar‐backbone  binding  and  finally  covalent  binding.[2]  More  recently,  a  new  DNA binding mode was reported: DNA junction binding.[9] 







Figure  1.3  Chemical  Structures  of  minor  groove  binding  drugs:  Berenil,  DAPI  Pentamidine  and Distamycin A.           











































PNAs  can  bind  in  the  DNA  major  groove  forming  triplex  DNA.  Structures  like (DNA)2(PNA)  are  formed  but  the  most  common  way  they  interact  is  through displacement of one DNA strands to form a stable (DNA)(PNA)2. The ability of PNAs to bind DNA has been  exploited  and  found many applications  in  the  last  two decades  as biotechnological tools and in medicine (anticancer, antiviral and antibacterial agents). In addition  PNAs  have  been  used  together  with  peptides  and  oligonucleotides  in  what remains  one  of  the  biggest  challenges  nowadays:  to  achieve  full  selective  DNA recognition.[13, 14] 
 


























































of complex.[1,  2,  21,  23] In addition, DNA‐sequence specificity was achieved by attaching a peptide  to  the  well  known  Rh(III)  metallo‐intercalator  [Rh(phi)2(phen)]3+.[24]  In  this example,  the metal  complex  provides  the  energy  for  the  interaction with  DNA  in  the major groove and the peptide provides the sequence specificity.[1, 25, 26] A more detailed discussion  on metallo‐intercalators  and  their  function with  DNA will  be  presented  in section 1.4. 
 




















































































Several  cisPt‐DNA  adducts  can  be  observed:  1,2‐intrastrand  GG  (~  65%)  and  1,2‐intrastrand AG  crosslinks  (25%)  are  the major  ones.[37]  The  binding  process  causes  a lesion that forces the double strand to unwind by 13° and bend the DNA by 45° near the coordination site (Figure 1.12, A).[38]        
 








































DNA a related Y shaped fork structure (a 3WJ in which a strand is not joined up) is found in  its  replication process. The Hannon group  in  collaboration with  the Coll  laboratory was  able  to  crystallise  and  structurally  characterize  the  interaction  between  a palindromic hexanucleotide DNA 3WJ with an iron(II) supramolecular cylinder (Figure 1.15).[9]        













Molecules that target 4WJs are primarily based on agents that recognize two B‐DNA arms  of  the  structure.  Lowe’s  bis‐acridines,  rigid  bis‐intercalators,  and  Sasaki’s  bis‐Hoechst agents target 4WJs in this way but with different motifs (Figure 1.17).[55‐57]   
    
 






























































































































double stranded helicates. These architectures were inspired by the work performed on dichlorobis(2‐phenylazopyridine)ruthenium(II)  complexes,  [Ru(Lazpy)2Cl2].  Reedijk  and co‐workers have intensively studied this family of mononuclear complexes, due to their cytotoxic activity in different human tumour cell lines. In particular, the α (Figure 1.25) configuration is the most active isomer with good stability and reasonable solubility.[84‐
86]      
Figure 1.25 Schematic representation of the compound α‐[Ru‐(Lazpy)2Cl2]. 












































 Pentaammine(purine)ruthenium (III) was reported by Clarke and co‐workers in the 70’s  as  the  first  ruthenium  complex  showing  in  vitro  activity  against  carcinoma  cells. From  this  point  a  growing  interest  in  ruthenium  complexes  as  potential  anticancer drugs has emerged.[104] Among several new ruthenium compounds, two of them are in clinical  trials:  trans‐[tetrachlorobis(1H‐indazole)ruthenate(III)]  (KP1019)[105]  and imidazolium  trans‐imidazoledimethylsulfoxidetetrachlororuthenate  (NAMI‐A)  which just completed phase I clinical trials (Figure 1.30).[106]         
 
 






























was  recently  showen  that  KP1019  binds  strongly  to  serum proteins  like  albumin  and transferrin,  which  are  very  important  for  the  drug  accumulation  inside  the  tumour, which occurs via transferrin pathway.[105, 107] The  anti‐metastatic  mechanism  of  NAMI‐A  remains  unclear  but  there  are  clear evidences  that  the metal centre plays a crucial  role  in  interacting with  the cell  surface and extracellular components like collagen.[106, 108, 109]  
 
 























































































































































































exhibit  significant  in  vivo  antitumor  activity  against  L1210  tumours,  Ehrlich  ascites, sarcoma 180 and P388 tumour lines.[90]     
   
 






















































































































































































































selectively to a  mismatch DNA duplex containing two AC mismatches (Figure 1.43).[152] A  crystal  structure  of  the  complex  bound  to  a  mismatched  DNA  allowed  structural characterization revealing that the compound intercalates at the mismatch site, ejecting the mismatched bases and replacing the pair with the aromatic four‐ring system of one of  the  ligands  (insertion) while  the  remaining  part  of  the  ligand  resides  in  the minor groove.[21,  152] The complex binds and cleaves 80% of mismatch DNA sites, with the Δ‐enantiomer being far more effective than the Λ‐enantiomer, which is almost inactive.[21, 


























































































a­Mathematical Physical and Engineering Sciences 1996, 354, 299. [2]  M. J. Hannon, Chemical Society Reviews 2007, 36, 280. [3]  M. H. Werner, A. M. Gronenborn, G. M. Clore, Science 1996, 271, 778. [4]  J. D. Watson, F. H. C. Crick, Nature 1953, 171, 964. [5]  G. L. Wang, L. A. Christensen, K. M. Vasquez, Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 2677. [6]  M. Balaz, M. De Napoli, A. E. Holmes, A. Mammana, K. Nakanishi, N. Berova, R. Purrello, 
Angew. Chem., Int. Ed. 2005, 44, 4006. [7]  J. R. Bothe, K. Lowenhaupte, H.M.Al‐Hashimi, J. Am. Chem. Soc. 2011, 133, 2016. [8]  N. V. Hud, Nucleic Acid­Metal Ion Interactions, RCS Publishing, 2009. [9]  A. Oleksi, A. G. Blanco, R. Boer, I. Uson, J. Aymami, A. Rodger, M. J. Hannon, M. Coll, Angew. 
Chem., Int. Ed. 2006, 45, 1227. [10]  P. G. Baraldi, A. Bovero, F. Fruttarolo, D. Preti, M. A. Tabrizi, M. G. Pavani, R. Romagnoli, 
Med. Res. Rev. 2004, 24, 475. [11]  M. J. Hannon, Pure Appl. Chem. 2007, 79, 2243. [12]  S.Neidle, Principle of nucleic acid structure, Elsevier Inc., London, 2008. [13]  P. E. Nielsen, M. Egholm, R. H. Berg, O. Buchardt, Science 1991, 254, 1497. [14]  L. Cardo, M. J. Hannon, Inorg. Chim. Acta 2009, 362, 784. [15]  L. S. Lerman, J. Mol. Biol. 1961, 3, 18. [16]  K. W. Jennette, J. T. Gill, J. A. Sadownick, S. J. Lippard, J. Am. Chem. Soc. 1976, 98, 6159. [17]  R. Martinez, L. Chacon‐Garcia, Curr. Med. Chem. 2005, 12, 127. [18]  P. J. Bond, Langridge, R.,  Jennette, K. W., Lippard, S.J., Proc. Natl. Acad. Sci. U. S. A. 1975, 





[27]  M. Galanski, B. K. Keppler, Anti­Cancer Agents Med. Chem. 2007, 7, 55. [28]  Rosenber.B, E. Renshaw, L. Vancamp, J. Hartwick, J. Drobnik, J. Bacteriol. 1967, 93, 716. [29]  B.  Lippert, Cisplatin,  Chemistry  and Biochemistry  of  a  Leading Anti­Cancer Drug, Wiley‐VCH, Weinheim, 1999. [30]  A. M. Pizarro, P. J. Sadler, Biochimie 2009, 91, 1198. [31]  B.Lippert, Cisplatin Chemistry and Biochemistry of a Leading Anticancer Drug, Wiley‐VCH, 
1999. [32]  D. Wang, G. Y. Zhu, X. H. Huang, S. J. Lippard, Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 9584. [33]  E. R. Jamieson, S. J. Lippard, Chem.Rev. 1999, 99, 2467. [34]  R. E. Mahnken, M. A. Billadeau, E. P. Nikonowicz, H. Morrison, J. Am. Chem. Soc. 1992, 114, 9253. [35]  C.  Sanchez‐Cano,  M.  Huxley,  C.  Ducani,  A.  E.  Hamad,  M.  J.  Browning,  C.  Navarro‐Ranninger, A. G. Quiroga, A. Rodger, M. J. Hannon, Dalton Trans. 2010, 39, 11365. [36]  M.  Huxley,  C.  Sanchez‐Cano,  M.  J.  Browning,  C.  Navarro‐Ranninger,  A.  G.  Quiroga,  A. Rodger, M. J. Hannon, Dalton Trans. 2010, 39, 11353. [37]  W. H. Ang, M. Myint, S. J. Lippard, J. Am. Chem. Soc. 2010, 132, 7429. [38]  S. F. Bellon, J. H. Coleman, S. J. Lippard, Biochemistry 1991, 30, 8026. [39]  P. M. Takahara, A. C. Rosenzweig, C. A. Frederick, S. J. Lippard, Nature 1995, 377, 649. [40]  U. M. Ohndorf, M. A. Rould, Q. He, C. O. Pabo, S. J. Lippard, Nature 1999, 399, 708. [41]  C. Sanchez‐Cano, M. J. Hannon, Dalton Trans. 2009, 10702. [42]  R. N. Bose, Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 18314. [43]  R. N. Bose, L. Maurmann, R. J. Mishur, L. Yasui, S. Gupta, W. S. Grayburn, H. Hofstetter, T. Milton, Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 18314. [44]  A. Harris, Y. Qu, N. Farrell, Inorg. Chem. 2005, 44, 1196. [45]  S. Komeda, T. Moulaei, K. K. Woods, M. Chikuma, N. P. Farrell, L. D. Williams, J. Am. Chem. 





2010, 20, 6956. [55]  M. Tanada, S. Tsujita, S. Sasaki, J. Org. Chem. 2006, 71, 125. [56]  M. L. Carpenter, G. Lowe, P. R. Cook, Nucleic Acids Res. 1996, 24, 1594. [57]  G. T. Song, J. S. Ren, Chem. Commun. 2010, 46, 7283. [58]  A. K. Todd, M. Johnston, S. Neidle, Nucleic Acids Res. 2005, 33, 2901. [59]  S. Haider, G. N. Parkinson, S. Neidle, J. Mol. Biol. 2002, 320, 189. [60]  S.  N.  Georgiades,  N.  H.  Abd  Karim,  K.  Suntharalingam,  R.  Vilar,  Angew.  Chem.,  Int.  Ed. 
2010, 49, 4020. [61]  K. L. Haas, K. J. Franz, Chem.Rev. 2009, 109, 4921. [62]  K. Suntharalingam, A. J. P. White, R. Vilar, Inorg. Chem. 2010, 49, 8371. [63]  S.  Rankin,  A.  P.  Reszka,  J.  Huppert,  M.  Zloh,  G.  N.  Parkinson,  A.  K.  Todd,  S.  Ladame,  S. Balasubramanian, S. Neidle, J. Am. Chem. Soc. 2005, 127, 10584. [64]  G.W.Collie, S. Sparapani, G.N.Parkinson, S. Neidle, J. Am. Chem. Soc. 2011. [65]  K.  M.  Rahman,  A.  P.  Reszka,  M.  Gunaratnam,  S.  M.  Haider,  P. W.  Howard,  K.  R.  Fox,  S. Neidle, D. E. Thurston, Chem. Commun. 2009, 4097. [66]  H. J. Yu, X. H. Wang, M. L. Fu, J. S. Ren, X. G. Qu, Nucleic Acids Res. 2008, 36, 5695. [67]  J. M. Lehn, Science 1993, 260, 1762. [68]  C. Piguet, G. Bernardinelli, G. Hopfgartner, Chem.Rev. 1997, 97, 2005. [69]  R. Kramer, J. M. Lehn, A. Marquisrigault, Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 5394. [70]  M. J. Hannon, V. Moreno, M. J. Prieto, E. Moldrheim, E. Sletten, I. Meistermann, C. J. Isaac, K. J. Sanders, A. Rodger, Angew. Chem., Int. Ed. 2001, 40, 880. [71]  M.  J. Hannon, C. L. Painting, A.  Jackson,  J. Hamblin, W. Errington, Chem. Commun. 1997, 1807. [72]  G. I. Pascu, A. C. G. Hotze, C. Sanchez‐Cano, B. M. Kariuki, M. J. Hannon, Angew. Chem., Int. 
Ed. 2007, 46, 4374. [73]  J.  C.  Peberdy,  J.  Malina,  S.  Khalid,  M.  J.  Hannon,  A.  Rodger,  Journal  of  Inorganic 




[78]  J. Malina, M. J. Hannon, V. Brabec, Nucleic Acids Res. 2008, 36, 3630. [79]  J. Malina, M. J. Hannon, V. Brabec, Chem.Eur. J. 2008, 14, 10408. [80]  C. Ducani, A. Leczkowska, N. J. Hodges, M. J. Hannon, Angew. Chem. Int. Ed 2010, 49, 1. [81]  A. C. G. Hotze, N. J. Hodges, R. E. Hayden, C. Sanchez‐Cano, C. Paines, N. Male, M. K. Tse, C. M. Bunce, J. K. Chipman, M. J. Hannon, Chemistry & Biology 2008, 15, 1258. [82]  L. J. Childs, J. Malina, B. E. Rolfsnes, M. Pascu, M. L. Prieto, M. L. Broome, P. M. Rodger, E. Sletten, V. Moreno, A. Rodger, M. J. Hannon, Chem.Eur. J. 2006, 12, 4919. [83]  L. J. Childs, M. Pascu, A. J. Clarke, N. W. Alcock, M. L. Hannon, Chem.Eur. J. 2004, 10, 4291. [84]  A. C. G. Hotze, E. P. L. van der Geer, H. Kooijman, A. L. Spek, J. G. Haasnoot, J. Reedijk, Eur. 
J. Inorg. Chem. 2005, 2648. [85]  A. C. G. Hotze, E. P. L. van der Geer, S. E. Caspers, H. Kooijman, A. L. Spek, J. G. Haasnoot, J. Reedijk, Inorg. Chem. 2004, 43, 4935. [86]  A.  C.  G.  Hotze,  A.  H.  Velders,  F.  Ugozzoli,  M.  Biagini‐Cingi,  A.  M. Manotti‐Lanfredi,  J.  G. Haasnoot, J. Reedijk, Inorg. Chem. 2000, 39, 3838. [87]  A. C. G. Hotze, B. M. Kariuki, M. J. Hannon, Angew. Chem., Int. Ed. 2006, 45, 4839. [88]  A. H. Velders, K. van der Schilden, A. C. G. Hotze, J. Reedijk, H. Kooijman, A. L. Spek, Dalton 
Trans. 2004, 448. [89]  A.Pope,  Supramolecular  Anticancer  Agents  and  Their  Effects  on  Cells  and  Biomelecules, 
PhD Thesis, University of Birmingham, Birmingham, 2010. [90]  H. T. Chifotides, K. R. Dunbar, Acc. Chem. Res. 2005, 38, 146. [91]  S. H. van Rijt, P. J. Sadler, Drug Discovery Today 2009, 14, 1089. [92]  H. Junicke, J. R. Hart, J. Kisko, O. Glebov, I. R. Kirsch, J. K. Barton, Proc. Natl. Acad. Sci. U. S. 




[103]  D. E. J. G. J. Dolmans, D. Fukumura, R. K. Jain, Nat. Rev. Cancer 2003, 3, 380. [104]  Y. K. Yan, M. Melchart, A. Habtemariam, P. J. Sadler, Chem. Commun. 2005, 4764. [105]  C.  G.  Hartinger,  M.  A.  Jakupec,  S.  Zorbas‐Seifried,  M.  Groessl,  A.  Egger,  W.  Berger,  H. Zorbas, P. J. Dyson, B. K. Keppler, Chem. Biodiversity 2008, 5, 2140. [106]  M. M. Liu, Z. J. Lim, Y. Y. Gwee, A. Levina, P. A. Lay, Angew. Chem., Int. Ed. 2010, 49, 1661. [107]  P. Heffeter, K. Bock, B. Atil, M. A. R. Hoda, W. Korner, C. Bartel, U. Jungwirth, B. K. Keppler, M.  Micksche,  W.  Berger,  G.  Koellensperger,  Journal  of  Biological  Inorganic  Chemistry 
2010, 15, 737. [108]  A. Bergamo, G. Sava, Dalton Trans. 2007, 1267. [109]  G. Sava, S. Zorzet, C. Turrin, F. Vita, M. Soranzo, G. Zabucchi, M. Cocchietto, A. Bergamo, S. DiGiovine, G. Pezzoni, L. Sartor, S. Garbisa, Clinical Cancer Research 2003, 9, 1898. [110]  C. Metcalfe, J. A. Thomas, Chem. Soc. Rev. 2003, 32, 215. [111]  L. Xu, G. L. Liao, X. A. Chen, C. Y. Zhao, H. Chao, L. N. Ji, Inorg. Chem. Commun. 2010, 13, 1050. [112]  X. L. Liang, L. F. Tan, Aust. J. Chem. 2010, 63, 1453. [113]  P. Nordell, F. Westerlund, L. M. Wilhelmsson, B. Norden, P. Lincoln, Angew. Chem., Int. Ed. 
2007, 46, 2203. [114]  M. R. Gill,  J. Garcia‐Lara, S.  J. Foster, C. Smythe, G. Battaglia,  J. A. Thomas, Nature Chem. 
2009, 1, 662. [115]  J. K. Barton, A. T. Danishefsky, J. M. Goldberg, J. Am. Chem. Soc. 1984, 106, 2172. [116]  D. A. Lutterman, A. Chouai, Y. Liu, Y. Sun, C. D. Stewart, K. R. Dunbar, C. Turro, J. Am. Chem. 
Soc. 2008, 130, 1163. [117]  Q. X. Zhou, W. H. Lei, Y. Sun, J. R. Chen, C. Li, Y. J. Hou, X. S. Wang, B. W. Zhang, Inorg. Chem. 





[126]  H. T. Chifotides,  J. M. Koomen, M.  J. Kang, S. E. Tichy, K. R. Dunbar, D. H. Russell,  Inorg. 
Chem. 2004, 43, 6177. [127]  D. V. Deubel, H. T. Chifotides, Chem. Commun. 2007, 3438. [128]  J. D. Aguirre, A. M. Angeles‐Boza, A.  Chouai,  C.  Turro,  J.  P.  Pellois,  K. R. Dunbar, Dalton 
Trans. 2009, 10806. [129]  J. D. Aguirre, H. T. Chifotides, A. M. Angeles‐Boza, A. Chouai, C. Turro, K. R. Dunbar, Inorg. 
Chem. 2009, 48, 4435. [130]  L. E. Joyce, J. D. Aguirre, A. M. Angeles‐Boza, A. Chouai, P. K. L. Fu, K. R. Dunbar, C. Turro, 
Inorg. Chem. 2010, 49, 5371. [131]  T. Mohammad, Toxicol. in Vitro 2004, 18, 45. [132]  D. Loganathan, H. Morrison, Curr. Opin. Drug Discovery Dev. 2005, 8, 478. [133]  E. L. Menon, R. Perera, M. Navarro, R. J. Kuhn, H. Morrison, Inorg. Chem. 2004, 43, 5373. [134]  A. A. Holder, D. F. Zigler, M. T. Tarrago‐Trani, B. Storrie, K. J. Brewer, Inorg. Chem. 2007, 
46, 4760. [135]  M. Harlos, I. Ott, R. Gust, H. Alborzinia, S. Wolfl, A. Kromm, W. S. Sheldrick, J. Med. Chem. 
2008, 51, 3924. [136]  M.  Dobroschke,  Y.  Geldmacher,  I.  Ott,  M.  Harlos,  L.  Kater,  L.  Wagner,  R.  Gust,  W.  S. Sheldrick, A. Prokop, ChemMedChem 2009, 4, 177. [137]  M. A. Scharwitz, I. Ott, Y. Geldmacher, R. Gust, W. S. Sheldrick, J. Organomet. Chem. 2008, 
693, 2299. [138]  U.  Sliwinska,  F.  P.  Pruchnik,  I.  Pelinska,  S.  Ulaszewski,  A. Wilczok,  A.  Zajdel,  Journal  of 
Inorganic Biochemistry 2008, 102, 1947. [139]  F. P. Pruchnik, P. Jakimowicz, Z. Ciunik, J. Zakrzewska‐Czerwinska, A. Opolski, J. Wietrzyk, E. Wojdat, Inorg. Chim. Acta 2002, 334, 59. [140]  A. A. Holder, S. Swavey, K. J. Brewer, Inorg. Chem. 2004, 43, 303. [141]  D. F. Zigler, M. T. Mongelli, M. Jeletic, K. J. Brewer, Inorg. Chem. Commun. 2007, 10, 295. [142]  M. Elvington, K. J. Brewer, Inorg. Chem. 2006, 45, 5242. [143]  M. J. Hannon, Coord. Chem. Rev. 1997, 162, 477. [144]  C. L. Kielkopf, K. E. Erkkila, B. P. Hudson, J. K. Barton, D. C. Rees, Nature Structural Biology 







































  The bisphenylazopyridine  ligand  (Lazo) was  synthesized  from 2‐nitrosopyridine and 4,4’‐methylenedianiline.[8] For the synthesis of the ligand a diamine spacer was added to 2‐nitrosopyridine in a ratio of 1 to 2.5 (Scheme 2.1).   
 
 




chromatography shows the higher stability in comparison with the imine ligand, which cannot  be  readily  purified  by  chromatography method  due  to  hydrolysis  of  the  imine bond.  The  orange  ligand  was  obtained  in  65%  yield  and  characterized  by  MS  and elemental  analysis,  which  were  in  accordance  with  the  synthesis  of  [C23H18N6].    MS spectrum  showed  fragments  corresponding  to  the  species  [C23H18N6+  H+]+  and [C23H18N6+ Na+]+. The 1H‐NMR revealed one set of nine resonances consistent with the formation of a symmetrical molecule. 
 








Scheme 2.2 Synthetic route for the preparation of the dinuclear single stranded complexes.   Prolonged  reaction  times  (up  to  3  hours)  led  to  the  formation  of  a  black  insoluble material that could be removed by filtration but resulted in a lower yield of the desired product. This  is  in accordance with previous observations reported by Brewer and co‐workers  during  the  synthesis  of  mixed  metal  Rh(III)  containing  supramolecular complexes.[12] While  mass  spectrometry  analysis  of  the  crude  mixtures  revealed  the  presence  of only  the  desired  complex with  peaks  corresponding  to  [Rh2(Lazo)(phen)2Cl4]2+  (m/z  = 543)  and  [Rh2(Lazo)(phen)2Cl4](PF6)+  (m/z  =  1231)  or  to  [Rh2(Lazo)(bpy)2Cl4]2+(m/z  = 518) and [Rh2(Lazo)(bpy)2Cl4](PF6)+ (m/z = 1180) with the correct isotopic pattern, the 


















The presence of the two metal centres in the molecule affords seven potential isomers, four of which have enantiomers. The 1H‐NMR spectra  indicate  that a smaller subset of the possible seven are present. Initial attempts to separate the isomers on alumina or silica columns using a number of eluents  including  organic  solvents,  mixtures  of  organic  solvents  and  water,  aqueous solutions  of  NaCl,  NH4PF6  or  KNO3  were  unsuccessful.  Eventually  a  HPLC chromatography method was established which enabled successful separation of two of the different isomers.  




loading  sample  size  was  found  to  be  critical  to  achieve  separation.  The  optimal  load injection found was of 10 mg of solid dissolved in 1 ml of acetonitrile.           
 




attempts  to optimize  the method, successful separation was achieved. An advantage  is that  it was possible  to maintain  the preparative HPLC  column always under  the  same experimental  conditions  allowing  reproducible  results  for  all  the  separations.  The optimal conditions were achieved by injecting each time approximately 10 mg of crude product  in  0.7  ml  of  acetonitrile  containing  0.01  %  of  TFA.  The  TFA  improved  the resolution  and  resulted  in  sharper peaks.  The preparative  chromatogram  for  the  final separation is shown in Figure 2.6.            
 
 



































Figure 2.7 Preparative HPLC chromatogram of a crude sample for [Rh2(Lazo)(bpy)2Cl4](PF6)2 showing the final  separation  for  the  three  isomers  with  the  gradient  method  CH3CN  (0.01 %TFA)  and  water  (0.01 %TFA).    Isomers 1 and 2 for [Rh2(Lazo)(phen)2Cl4](PF6)2  will be named complexes 1 and 2 and Isomers 1 and 2 for [Rh2(Lazo)(bpy)2Cl4](PF6)2 will be named 3 and 4.  These  four  complexes  were  isolated  and  further  characterized  by  MS,  1H‐NMR, elemental analysis and UV‐Vis.  Complex 1 was  obtained with  a  final  yield  of  20% and 2 with  18%. The  elemental analysis  for  1  and  2  support  a  [Rh2(Lazo)(phen)2Cl4](PF6)2  formulation.  The  ESI‐MS spectra of the complexes (acetonitrile, low cone voltage of 5 eV) of both complexes 1 and 









In  the  absorption  spectra  recorded  in  acetonitrile,  the  visible  region  of 1  and 2  is dominated by an MLCT transition at 399 nm (ε399 = 15 500 dm3 mol‐1 cm‐1 for 1 and ε399 = 20 800 dm3 mol‐1 cm‐1 for 2) while the UV region is dominated by strong π‐π* ligand transitions at 274 nm (ε274 = 49 600 dm3 mol‐1 cm‐1 for 1 and ε274 = 66 400 dm3 mol‐1 cm‐1  for  2).  These  data  are  in  accordance  with  those  for  similar  complexes  such  as [Rh(phen)2Cl2].[13]  Complexes 3 and 4 were obtained in similar yields to 1 and 2. The elemental analysis data for 3 and 4 support the [Rh2(Lazo)(bpy)2Cl4](PF6)2 formulation and the MS for both complexes (under the same conditions as for 1 and 2) is again dominated by the doubly charged species [Rh2(Lazo)(bpy)2Cl4]2+ (m/z = 518) with the correct isotopic pattern and minor  singly  charged  species  [Rh2(Lazo)(bpy)2Cl4]+  and  [Rh2(Lazo)(bpy)2Cl4](PF6)+ with 
m/z = 1036 and m/z = 1180. The absorption spectra recorded in acetonitrile show that the visible region of 3 and 4 is dominated by an MLCT transition at 390 nm (ε390=13 520 dm3 mol‐1  cm‐1  for 3  and  ε390  =  18  230  dm3 mol‐1  cm‐1  for 4)  while  the  UV  region  is dominated by strong π‐π* transitions at 250 nm (ε250 = 42 320 dm3 mol‐1 cm‐1 for 3 and 














































dominated  by  the  singly  charged  species  at  m/z  =  536  corresponding  to [Rh(Lazpy)(phen)Cl2]+ or m/z  =  512 corresponding to [Rh(Lazpy)(bpy)Cl2]+.  The  UV‐Vis  spectra  of  5  and  6  are  similar  to  those  of  the  dinuclear  analogues  as expected. The absorption spectrum of 5 is dominated by two UV transitions assigned as 
π‐π*  transitions  of  the  ligand  at  227  nm  (ε227  =  45  230  dm3  mol‐1  cm‐1)  and  π‐π* transitions  of  the  phen  ligand  at  274  nm  (ε274  =  33  133  dm3  mol‐1  cm‐1).  The  MLCT transition is blue shifted (375 nm with ε375 = 9 985 dm3 mol‐1 cm‐1) in comparison with the  dinuclear  analogues  1  and  2.  The  UV‐Vis  spectrum  of  6  has  two  UV  transitions assigned as π‐π* transitions of the ligand at 227 nm (ε227 = 27 033 dm3 mol‐1 cm‐1) and π‐









† UV-vis spectrum recorded at r.t in acetonitrile.[13]  
 


































































Figure  2.9  Crystal  packing  of  5.  Each  rhodium  complex  of  5  is  connected  to  two  others  via  an  inter‐molecular  π‐π  stacking  interaction.  PF6  anions  and  all  hydrogen  atoms  have  been  omitted  for  clarity. Carbon  atoms  are  shown  in  grey,  rhodium  in  pink,  chlorine  in  green  and  nitrogen  in  blue,  while  π‐π stacking interactions are indicated by black dotted lines. 
 
 











Figure 2.10 Crystal structure of polymorph of cis‐[Rh(Lazpy)(phen)Cl2](PF6) (5)  in methanol:acetonitrile. Hydrogen  atoms  have  been  omitted  for  clarity.  For  crystallographic  data  and  refinement  details  see Appendix A.3 Table 1. 
 
 
Figure 2.11 Crystal packing of polymorph of 5. Each rhodium complex of 5 is connected to one other via an inter‐molecular π‐π stacking. PF6 anions and all hydrogen atoms have been omitted for clarity. Carbon atoms  are  shown  in  grey,  rhodium  in  pink,  chlorine  in  green  and  nitrogen  in  blue,  while  π‐π  stacking interactions are indicated by black dotted lines. 






















The  X‐ray  structure  of  6  (Figure  2.13)  confirms  the  formation  of  a  Rh(III) mononuclear  complex.  The  metal  centre  occupies  a  six‐coordinated  octahedral environment with the Rh‐N bonds all with similar length (2.03‐2.04 Å) and similar to the previous structure 5 as well as the Rh‐Cl bonds, both with 2.33 Å. Selected bond lengths 
for 6 are shown in Table 2.3. Additionally, the structure confirms that the chloride atoms are  coordinated  to  the  metal  centre  in  cis  configuration  and  the  pyr  in  trans configuration  to  the  bpy  ring  as  in 5.  The  phenyl  ring  is  twisted  with  respect  to  the phenylazo  unit  of  ‐35.1  (6)°  and  is  placed  above  the  central  ring  of  the  bpy  but  the distances  are  too  long  (and  the  ring  not  sufficient  coplanar)  to  propose  strong intramolecular π‐π stacking interaction.        





















The crystal packing of cis‐[Rh(Lazpy)(bpy)Cl2](PF6) (Figure 2.14) shows each rhodium complex  of 6  is  connected  to  two  others  via  inter‐molecular π‐π  stacking  interactions between two pyr rings of the bpy containing C(13) with an inter‐planar separation of 3.5 Å and between two pyr rings containing C(20), with an inter‐planar separation of 3.4 Å.  
 
 






















The  molecular  structure  of  1  (Figure  2.17)  was  determined  by  X‐ray  diffraction analysis and the crystal structure reveals this dinuclear complex to be the Rac (ΔΔ,ΛΛ) isomer.  Each  Rh(III)  centre  has  an  octahedral  geometry  as  before,  with  Rh‐N  bonds distances all with close lengths (2.01‐2.05 Å). The structure shows the chlorides in a cis position  in each metal  centre and  the pyr  ring of  the Lazo  in  trans  configuration  to  the phen  ligand,  as anticipated  from  the  1H‐NMR. The  configuration of  the  ligands  in each metal  centre  in 1  is  similar  to 5.  All  of  the  four Rh‐Cl  bonds have  lengths  in  between 2.31‐2.33 Å, which is equivalent to the ones obtained for 5. Selected bond lengths for 1 are  shown  in  Table  2.4.  The  Rh‐Rh  distance  is  10.2  Å  which  although  similar  to,  is slightly smaller than the metal‐metal distance observed for the Fe(II) (11.4 Å) and Ru(II) triple (11.3 Å) stranded helicates and for the Ru(II) double stranded helicates (12.1‐12.5 Å, for different isomers).[4, 5, 8]       
 

























 2.321(4) 2.335(4)  2.017(12)  2.017(12)  2.041(12) 2.046(11)  1.253(16) 
Rh­2 
2.311(4) 2.333(4)  2.021(12)  2.005(13)   2.042(14) 2.076(14)  1.237(17) 
 






























4 were unsuccessful.  The  molecular  structure  of  3  (Figure  2.20)  was  determined  by  X‐ray  diffraction analysis and the crystal structure reveals the dinuclear complex to be the Rac (ΔΔ,ΛΛ) isomer.        
 
 
Figure  2.20  Crystal  structure  of  ΔΔ,ΛΛ‐[Rh2(Lazo)(bpy)2Cl4](PF6)2  (3).  The  PF6  anions  and  acetonitrile molecules and all hydrogen atoms have been omitted for clarity. For crystallographic data and refinement details see Appendix A.12 Table 4.   Each Rh(III)  centre has an octahedral geometry with Rh‐N bonds distances all with lengths  in between 1.98‐2.04 Å. The  structure  shows  the  chlorides  in  a cis  position  in each metal centre and the pyr ring of the Lazo in trans configuration to the bpy ligand as anticipated  from the 1H‐NMR spectrum. The configuration of  the  ligands  in each metal centre in 3 is similar to what it occurs in the mononuclear analogue 6 as well as in 1 and 























 2.345(2) 2.336(2)  1.985(6)  2.031(6)  2.0249(6) 2.029(7)  1.263(9) 
Rh­2 
 2.329(2) 2.336(2)  2.014(7)  2037(7)  2.021(7) 2.027(6) 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minutes,  the  mixture  turns  to  a  very  strong  yellow/green  colour.  The  warm  crude mixture  is  filtered  through  celite  to  separate  the  compound  from  the  insoluble  black polymer. After cooling to room temperature, the green complex is obtained as a PF6 salt by  the  addition  of  a  concentrated  aqueous  NH4PF6  solution.  The  ESI‐MS  of  the  crude mixture  is dominated by  the doubly  charged peak of  the  species  [Rh2(Lazo)2Cl4]2+ with 























separation  and  purification,  the major  isomer  was  obtained  with  a  2%  yield  and  the minor one with 1%. While the yields for these two isomers were low, these are the first examples  of  double  stranded  Rh(III)  supramolecular  complexes  and  the  quantities obtained were enough for characterization and biological evaluation.  After  HPLC  separation  and  purification  the  complexes  were  isolated  and characterized by ESI‐MS, 1H‐NMR, elemental analysis and UV‐Vis spectroscopy. The first isomer collected, the minor one, will be named complex 7 and the major isomer complex 
8.  Elemental  analysis data  for 7 and 8  support  a  [Rh2(Lazo)2Cl4](PF6)2  formulation and the  ESI‐MS  of  both  complexes  is  dominated  by  a  peak  with  the  correct  pattern  for [Rh2(Lazo)2Cl4]2+ (m/z = 552) as well singly charged species [Rh2(Lazo)2Cl4]+ (m/z = 1104) and [Rh2(Lazo)2Cl4](PF6)+ with m/z = 1248. In the absorption spectra of both isomers, the visible region is dominated by an MLCT transition centred at 408 nm (ε408 = 58 750 dm3 mol‐1cm‐1  (7)  and  60  606  dm3  mol‐1cm‐1  (8)).  The  third  peak  was  also  collected  and identified by MS as a third isomer, although it was difficult to collect enough material for a  1H‐NMR  spectrum.  Several  HPLC  injections  of  additional  amounts  of  crude  from different reactions allowed collecting the third peak in a sufficient quantity to perform 
















































































































































refluxing mixture of ethanol:water  (2:1),  led  to  the precipitation of AgCl and upon hot filtration,    1.5  equivalents  of  Lazo were  added  to  the mixture  and  refluxed  for  1  extra hour. The MS of the crude reaction mixture was analyzed and showed a set of peaks that suggested  the  formation  of  the  desired  complex  along  with  several  other  peaks indicating  the  presence  of  other  species  formed  by  the  non‐total  substitution  of  the chloride ligands by the nitrates. As a consequence, new efforts were made starting from the commercial available Rhodium (III) nitrate (Rh(NO3)3.xH2O). The use of this starting material with nitrates and water ligands as good leaving groups, would lead to a water soluble complex which can be used directly for DNA binding and biological studies.   
2.7.1 Synthesis of Rh(III) Triple Stranded Complex  




The  MS  of  the  Rh(III)  triple  helicate  complex  when  the  PF6  salt  was  dissolved  in acetonitrile  (MS,  5  eV,  injected  via  syringe  pump  in  acetonitrile) was  dominated  by  a doubly charged peak corresponding to [Rh2(Lazo)3]2+ with m/z = 670, and triply and four charged peaks [Rh2(Lazo)3]3+,[Rh2(Lazo)3]4+ with m/z = 446 and m/z = 335, respectively. Also a singly charged peak was observed for the species [Rh2(Lazo)3](PF6)+ at m/z = 1486 (Figure  2.30).  
          
 





















































  As  the  phenyl  rings  of  the  spacer  are  freely  rotating  in  solution  the  corresponding protons  appear  as  two  sharp  doublets  at  8.09  and  7.58  ppm.  The  coordination  of  the ligand to the metal is confirmed by the large downfield shift of all the aromatic protons 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1cm‐1). Numerous  attempts were made  to  grow  X‐ray  quality  crystals  of  this  complex,  but unfortunately such efforts were unsuccessful. 
With the aim to explore the emission properties of complex 10, experiments were carried out in water with a different range of excitation wavelengths. This study showed that the complex emits poorly at room temperature under these conditions. This result was  not  totally  unexpected  because  complexes  like  [Rh(phen)3]3+  and  [Rh(bpy)2Cl2]+ show weak emission at room temperature and with emission properties explored at 77 Kelvin in ethanol‐methanol glass.[13, 22, 23] 
 
2.8 New Mononuclear Facial Isomer of Rh(III) 














































































2.10.3 Synthesis of [Rh(DMSO)(bpy)Cl3][7]   [Rh(DMSO)(bpy)Cl3]  was  synthesized  according  to  the  same  literature  procedure.[7] 
























UV‐Vis  (CH3OH) λmax  (εmax/dm3 mol‐1  cm‐1) 227 (22 766), 334 (44 033), 350 (39 133), 447 (2 600) nm.  









 [Rh(DMSO)(phen)Cl3]  (0.200  g,  0.43  mmol)  and  Lazo  (0.032  g,  0.09  mmol)  were suspended  in a mixture of propanol:water (2:1) (70 ml) and heated under reflux  for a period  of  40 minutes.  The  starting  orange  solution  becomes  light  brown  and  after  15 minutes  of  reflux  the  solution  becomes  green  and  is  left  refluxing  for  an  extra  25 minutes. The reaction mixture was cooled down to room temperature and the complex precipitated as a PF6 salt by addition of a concentrated aqueous solution of NH4PF6. The resulting dark green precipitate was washed with 1 ml of water to remove the excess of salt  and dried with diethyl  ether  (2 ml). The  complex was  re‐dissolved  in  a minimum amount of acetonitrile and precipitated with diethyl ether (0.100 g).  
 Positive‐ion  ESI  (5  eV,  CH3CN,):  m/z  (%)  543  [Rh2(Lazo)(phen)2Cl4]2+  (100),  1086 [Rh2(Lazo)(phen)2Cl4]+ (10),  1231  [Rh2(Lazo)(phen)2Cl4][PF6]+ (10).  
 
2.10.6 Separation of the Isomers by Preparative HPLC 




TFA) is increased to 30% over a period of 20 minutes, staying at (70:30) water (0.01% TFA):acetonitrile  (0.01% TFA)  for a period of 15 minutes and  finally going back  to  the initial ratio of 85:15 and running for 5 minutes.  Retention time for ΔΔ,ΛΛ‐[Rh2(Lazo)(Phen)2Cl4](PF6)2] (1): 22.3 minutes. Retention time for ΔΛ‐[Rh2(Lazo)(Phen)2Cl4](PF6)2] (2):: 23.5 minutes.  In both cases the solutions containing the complexes after collections were concentrated in  vacuo  to  remove  the  excess  of  acetonitrile  and  the  yellow/green  product  was  re‐precipitated from a concentrated methanolic solution of NH4PF6 (excess).  
2.10.7 ΔΔ ,ΛΛ­[Rh2(Lazo)(phen)2Cl4](PF6)2  (1)  Positive‐ion  ESI  (5  eV;  CH3CN,):  m/z  (%)  543  [Rh2(Lazo)(phen)2Cl4]2+  (100),  1086 [Rh2(Lazo)(phen)2Cl4]+ (10),  1231  [Rh2(Lazo)(phen)2Cl4][PF6]+ (10).   Crystals suitable for X‐ray diffraction measurements were obtained by slow diffusion of ether into a nitromethane solution of a pure sample of complex.   
























UV‐Vis  (H2O) λ max  (εmax/dm3 mol‐1  cm‐1):   228 (50 033), 274    (38 100), 357 (11 266), 388 (12 033), 555 (2500) nm.  
 
2.10.8 ΔΛ­[Rh2(Lazo)(phen)2Cl4](PF6)2 (2)  Positive‐ion  ESI  (5  ev,  CH3CN):  m/z  (%)  =  543  [Rh2(Lazo)(phen)2Cl4]2+  (100),  1086 [Rh2(Lazo)(phen)2Cl4]+ (10),  1231  [Rh2(Lazo)pPhen)2Cl4][PF6]+ (10). 
Elemental  analysis  calcd  (%)  for  [Rh2(C23H18N6)(C12H8N2)2Cl4(PF6)2]:    C:41.0;  H:2.5;  N:10.2; found: C:40.9; H:2.5; N:10.2.  









ΔΛ­[Rh2(Lazo)(phen)2Cl4]Cl2  Positive‐ion ESI  (10 ev, H2O): m/z  (%) 538  [Rh2(Lazo)(phen)2Cl(MeOH)3]2+  (100),  1076 [Rh2(Lazo)(phen)2Cl(MeOH)3]+ (20).  UV‐Vis (H2O) λmax (εmax/dm3 mol‐1cm‐1): 227 (57 533), 275  (40 900.0), 357 (10 733), 392 (12 266), 556 (1566) nm. 
 
2.10.9 Synthesis of [Rh2(Lazo)(bpy)2Cl4](PF6)2 
 [Rh(DMSO)(bpy)Cl3] (0.200 g, 0.45 mmol) and Lazo (0.034 g, 0.09 mmol) were suspended in  a mixture of propanol:water  (2:1)  (70 ml)  and  refluxed  for  a period of 40 minutes. The  starting  orange  solution  becomes  light  brown  and  after  15 minutes  of  reflux  the solution becomes green and is left refluxing for 25 minutes more. The reaction mixture was  cooled  down  to  room  temperature  and  the  complex  precipitated  as  a  PF6  salt  by addition  of  a  concentrated  aqueous  solution  of  NH4PF6.  The  resulting  dark  green precipitate was washed with 1 ml of water to remove the excess of salt and dried with diethyl ether (2 ml). The complex was re‐dissolved in a minimum amount of acetonitrile and precipitated with diethyl ether (0.090 g).  





2.10.10 Separation of the Isomers by Preparative HPLC  The isomers were separated using the same HPLC method as for the previous complexes. The  final  method  utilises  a  reverse  phase  C18  preparative  column  and  starts  with  a mixture of water (0.01% TFA): acetonitrile (0.01% TFA) (85:15) that runs for a period of 5 minutes, after which time the ratio of (0.01% TFA) is increased to 30% over a period of 20 minutes, staying at (70:30) water (0.01% TFA):acetonitrile (0.01% TFA) for a period of  15  minutes  and  finally  going  back  to  the  initial  ratio  of  85:15  and  running  for  5 minutes.  Retention time for ΔΔ,ΛΛ‐[Rh2(Lazo)(bpy)2Cl4](PF6)2 (3): 21.7 minutes. Retention time for ΔΛ‐[Rh2(Lazo)(bpy)2Cl4](PF6)2 (4):: 22.9 minutes. 
 


























UV‐VIS  (H2O)  λmax  (εmax/dm3 mol‐1  cm‐1):  248  (18 200),  311  (14 333),  386  (7 666),  590 (900) nm. 
 
2.10.12 ΔΛ­ [Rh2(Lazo)(Bpy)2Cl4](PF6)2 (4)  Positive‐ion  ESI  (5  ev,  CH3CN):  m/z  (%)    =  518  [Rh2(Lazo)(bpy)2Cl4]2+  (100),  1036 [Rh2(Lazo)(Bpy)2Cl4]+ (10).  Elemental  analysis  calculated  (%)  for  [Rh2(C23H18N6)(C10H8N2)2Cl4(PF6)2]:  C:38.9;  H:2.6; N:10.5 found: C:39.2; H:2.5; N:10.9.  UV‐Vis (CH3CN) λmax (εmax/dm3 mol‐1 cm‐1): 250 (50 312), 390 (18 230) nm. nm.   
1H NMR (400 MHz, CD3CN, 25 °C, TMS) δ= 9.68 (d, 1H, J = 5.4 Hz, H6pyr); 9.51 (d, 1H, J = 5.8 Hz H6bpy); 8.89 (d, 1H, J = 7.5 Hz, H3pyr); 8.75 (td, 1H, J = 7.9, 1.6 Hz H4pyr); 8.39 (d, 1H, J = 7.4 Hz, H3bpy); 8.33‐8.23 (m, 4H, H5pyr/H4/4’/3bpy); 7.79 (m, 1H, H5bpy); 7.66 (d, 1H, J = 5.8 Hz, H6’bpy); 7.57 (m, 1H, H5’bpy); 7.04 (d, 2H, J = 8.5 Hz, Hph); 6.95 (d, 2H, J = 8.5 Hz, Hph); 3.88 (s, 1H, CH2);  
 




UV‐VIS  (H2O) λmax  (εmax/dm3 mol‐1  cm‐1):  247  (15 666), 313  (12 300), 396  (8 000), 590 (566) nm.  






























13C  NMR  (100 MHz,  CD3CN,  25°C,  TMS):  δ  =  152.7  (C2phen/C6pyr),  152.1  (C9phen),  140.6 (C4phen) , 140.4 (C4pyr/C4phen/C7phen),127.0 (C8phen);  
 
































cis­[Rh(Lazpy)(bpy)Cl2]Cl   Positive‐ion  ESI  (10  eV,  H2O,):  m/z  (%)  512  [Rh(Lazpy)(bpy)Cl2)]+  (100),  508 [Rh(Lazpy)(bpy)Cl (MeOH‐2H)]+ (50). 
1H NMR (400 MHz, CD3OD, 25 °C, TMS): δ= 9.70 (d, 1H, J = 5.0 Hz, H6pyr); 9.61 (d, 1H, J = 5.8, H6bpy), 9.09 (d, 1H, J = 7.6 Hz, H3pyr); 8.78 (td, 1H, J = 8.0, 1.5 Hz, H4pyr); 8.53 (m, 2H, H3bpy/3’bpy); 8.29 (m, 3H, H5pyr/H4/4’bpy); 7.88 (m, 1H, H5bpy); 7.75 (d, 1H, J = 5.8 Hz, H6’bpy); 7.60 (m, 1H, H5’bpy), 7.45 (brt, 1H, J = 7.5 Hz, Hp); 7.24 (brt, 2H, J = 7.9 Hz, Hm); 7.13 (d, 2H, J = 7.9 Hz, Ho);  
 UV‐VIS  (H2O) λmax  (εmax/dm3 mol‐1  cm‐1):  235  (19 666), 313  (13 566), 375  (8 266), 590 (566) nm. 
 




 Positive‐ion  MS  (5  eV,  CH3CN):  m/z  (%)  =  552  [Rh2(Lazo)2Cl4]2+  (100),  1104 [Rh2(Lazo)2Cl4] (15).  Elemental analysis calcd (%) for [Rh2(C23H18N6)2Cl4(PF6)2] C: 39.6, H: 2.6, N: 12.1; found C: 39.5, H: 2.6, N: 12.1. 
 












 Positive‐ion  ESI  (5  eV,  CH3CN):  m/z  (%)  =  552  [Rh2(Lazo)2Cl4]2+  (100),  1104 [Rh2(Lazo)2Cl4] (15), 1249 [Rh2(Lazo)2Cl4](PF6)+ (10)  Elemental analysis calcd (%) for [Rh2(C23H18N6)2Cl4(PF6)2].2H2O C: 38.6, H: 2.8 N: 11.7; Found C:38.1, H:2.3,  N:11.4  
1H NMR (400 MHz, CD3CN, 25 °C, TMS): δ= 9.53 (d, 1H, J = 5.5 Hz, H6), 8.99 (t, 2H, J = 8.1 Hz, H3/3’), 8.76 (td, 1H, J = 8.6, 7.1Hz, H4), 8.59 (td, 1H, J = 7.8, 6.3 Hz, H4’), 8.28‐8.24 (m, 1H, H5), 7.90 (d, 1H, J = 5.5 Hz, H6’), 7.86‐7.80 (m, 1H, H5’), 7.74 (d, 2H, J = 8.6 Hz, Hph), 7.36 (dd, 4H, J = 8.6, 2.8 Hz, Hph/ph’), 7.21 (d, 2H, J = 8.6 Hz, Hph’), 4.21(s, 2H, CH2).   UV‐VIS (CH3CN) λmax (εmax/dm3 mol‐1 cm‐1): 408 (58 750) nm. 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3.1 Introduction This  chapter  aims  to  explore  the  DNA  binding  properties  of  the  complexes synthesized  in  chapter  2,  using  different  spectroscopic  techniques  and  gel electrophoresis.  For  these  studies  it  was  important  that  each  complex  had  good solubility in water and this was achieved for all the complexes obtained as PF6 salts (1, 
2, 3, 4, 5, 6, 7 and 8) by  ion exchange  to  the respective chloride salt using Dowex  ion exchange  columns.  In  case  of  complex 10  the  final  nitrate  salt  already  exhibited  high water solubility and it was used as obtained. The complexes exhibited good stability in water  at  room  temperature.  UV‐Vis  spectra were  recorded  each  30 minutes  during  a period of 12 hours and no significant differences were observed. The MS of the chloride salt  in water  for each complex 1  to 8 was carried out, however  it was not possible  to obtain  1H‐NMR  spectra  for  the  chloride  salt  of  the  single  and  double  stranded complexes, once when the complexes were dissolved in D2O they formed a gel (example can be seen from picture in Figure 3.1), which didn't allow the molecule to tumble on the NMR  timescale,  giving  rise  to  a  very  broad  unique  band  or  to  a  completely  flat  line spectrum. Gelating by a supramolecular helicate like complex that does not bear surface functional  groups  is  as  far  as  we  know  unprecedented.  This  may  be  related  to  the presence of the coordinated chloride ligands in each di‐nuclear complex. Although this happens  in  aqueous  conditions  for  NMR  this  does  not  affect  the  solutions  of  the 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complexes  used  for  DNA  binding  studies  since  the  concentration  needed  for  1H‐NMR spectra is at least four times higher than the one used for DNA binding studies (CD and LD).         
 

















Figure  3.2  Representation  of  a  linearly  (left)  and  circularly  polarized  light  (right)  of  electromagnetic radiation. The k vector indicates the direction of propagation and the arrows indicate the direction of the electric field vector (E).[1]    The difference in the absorbance (A) between the left (Al) and the right (Ar) circularly polarized  light  is  measured  as  a  wavelength  function  and  gives  rise  to  a  CD  signal according to the equation below.   CD = Al ‐ Ar 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Figure 3.3 CD Signal of 300 µM ct‐DNA (base pairs‐bp).    The CD spectrum of ct‐DNA is characterized by having a positive band centred at 280 nm  followed  by  a  negative  band  at  245  nm  and  an  intersection  point  at  the  UV absorption maximum (260 nm). Over 300 nm the DNA does not have any CD signal. 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Nonchiral  drug  molecules  (molecules  that  lack  handedness  and  thereby  optical activity)  have  no  CD  signal. However, when bound  to DNA,  nonchiral molecules  often give rise to a CD spectrum due to an  induced CD signal (ICD) resulting from the chiral environment  around  the  molecule.[1,  2]  This  effect  allows  the  DNA‐synthetic  agent interactions  to  be  probed  and  in  addition  the  binding  mode  (s)  by  which  the  drug molecule targets the DNA. 
  
3.3 UV­Visible ct­DNA Titrations with Rh(III) Complexes   UV‐Vis ct‐DNA (300 µM) titrations were carried out using complexes 1 to 6  (Figure 3.4).  Spectra  show  no  significant  changes  in  the  region  between  300‐500  nm  upon addition to ct‐DNA. The absorbance variation is linear (shown on respective plots of Abs 




























































3.4 CD ct­DNA Titrations with Rh(III) Complexes    To carry on exploring the binding affinities of the complexes with ct‐DNA, UV‐Visible absorbance circular dichroism (CD) was used. The experiments have been carried out with  calf  thymus  DNA  (ct‐DNA)  in  aqueous  solution  with  NaCl  (20 mM)  and  sodium cacodylate buffer (1 mM) pH 6.8, with a constant concentration of ct‐DNA (300 µM). For complex 10  (Rh(III)  triple  stranded  complex)  the  ct‐DNA  concentration  used was  80 
µM:  due  to  the  high  charge  of  the  complex  even  at  low  ratios  of  DNA:complex  dark orange/brown strands of DNA‐complex aggregates were formed when using higher DNA concentrations. None of the complexes studied showed intrinsic CD signals, in this way any CD signal that occurs  in  the spectroscopic  regions of  the complexes are  therefore a  result of  the interaction between the complexes and ct‐DNA.[6] 
 






















































 Titrations  of  ct‐DNA  (300  µM) with  complexes 3  and 4  were  carried  out  and  ICD signals observed at 311 and 439 nm proving that both complexes bind to DNA (Figure 3.10). Interestingly there are considerable differences comparing with complexes 1 and 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3.4.2 CD ct­DNA Titrations with Rh(III) Complexes (7 and 8)   Similar ct‐DNA (300 µM) CD titrations were performed using Rh(III) double stranded complexes under the same conditions. Increasing amounts of complexes 7 and 8  led to an induced ICD signal in the complex region with a positive band around 400 nm, which confirms  the  binding  to  ct‐DNA  (Figure  3.13).  The  B‐DNA  form  is  retained  although changes  are  observed  upon  addition  of  the  complexes  to  ct‐DNA  in  the  UV  region. Plotting of  the  ICD at 400 nm  for 7  and 8  (Figure 3.14),  show  that  the  second  isomer (complex 8)  has  clearly better binding  effect  to  ct‐DNA when  compared with  the  first 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The  fact  that  during  the  UV‐Vis  and  CD  titrations  none  of  the  spectra  of  the complexes show any shifts of the bands, suggests that the DNA binding interactions are non‐covalent under the conditions used for the titration experiments.    
3.4.3 CD ct­DNA Titrations with Rh(III) Triple Stranded 
Complex (10) 


























































The fact that the Rh(III) complex 10, the triple helicate, has a lower binding constant in  comparison with  the Fe(II)  and Ru(II)  cylinders  is unexpected as due  to  the higher charge  a  stronger  binding would  be  expected.  The Kb  value  of 10  although  higher  in comparison with the single ad double stranded Rh(III) dinuclear complexes its order of magnitude is lower than for the Ru(II) and Fe(II) cylinders. These last ones have similar binding, which was expected due to their similar supramolecular structure and overall charge. 
       












3.5 CD Studies with poly [G­C] and poly[A­T]   In  order  to  explore  if  some  of  the  complexes  exhibited  any  binding  preferences between different DNA sequences, CD studies were also carried out using poly[G‐C] and poly[A‐T]. For these first studies the complexes explored were the two single stranded complexes with phen ligands (1 and 2), as these were the ones that have a higher effect on ct‐DNA by CD spectroscopy. Also a similar experiment was carried out using one of the  double  stranded  isomers  (8).  The  CD  studies  with  poly[G‐C]  and  poly[A‐T]  were carried out in an analogous way to the ct‐DNA titrations. Solutions of the polymers (100 























































Figure  3.18  CD  of  100  µM  poly[G‐C]  (left)  and  poly[A‐T]  (right)  in  20  mM  NaCl  and  1  mM Na(CH3)2AsO2.3H2O  (pH  6.8)  with  increasing  concentrations  of  complexes  8.  The  legends  show  ct‐DNA:complex ratios. 
 




Linear dichroism (LD) is the difference between the absorption of linearly polarized light  both parallel  and perpendicular  to  a  chosen plane  and  can be used  to  probe  the orientation of  long molecules  like DNA (with a minimum  length of  approximately 250 base pairs), using a flow Couette cell containing sample being oriented through a viscous drag (Figure 3.19). [1]           




3.7 LD ct­DNA Titrations with Rh(III) Complexes   The  complexes  studied  are  too  small  to  exhibit  any  LD  signal  alone,  so  any  signals arising  from  the  experiment  in  the  spectroscopic  region  of  the  complexes  after  the addition  to  ct‐DNA  indicate  the  binding  of  the  complex  to  ct‐DNA  in  a  specific orientation. The LD titrations were performed using the same conditions as for the CD titrations. 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In addition complex 4 shows a second ILD band, although weak around 450 nm. The ILD  signal  observed  for  both  complexes,  proves  the  binding  to  DNA  in  a  specific orientation (s) and not merely randomly. The negative LD band (220‐300 nm) confirms retention of the B‐DNA conformation. This behaviour of the LD signal again is consistent with  a  non‐intercalative mode,  and  consistent  with  the  loss  of  DNA  orientation  from DNA coiling or bending. Complex 4 appears to cause more ct‐DNA coiling than complex 

































  Comparing the LD spectra of both mononuclear complexes 5 and 6, both spectra are similar. Complex 5 shows a slight bigger decrease of the negative LD band of the ct‐DNA at 260 nm suggesting that the complex causes a slightly bigger coiling/bending of the ct‐DNA than complex 6. Table  3.2,  shows  a  comparison  between  the  percentage  values  of  loss  of  LD  signal when ct‐DNA was titrated with each complex 1 to 6 for the highest DNA: complex ratio used (4:1). From this there  is a clear difference between the coiling/bending effects of the  di‐nuclear  single  stranded  complexes  in  comparison  with  the  mononuclear analogues, with the first ones having a stronger effect. Also, between the different single stranded complexes, the ones with phen ligands (1 and 2) seem to cause a higher coiling for the same DNA:complex ratio.    
Table 3.2 Comparison of the % of loss of LD signal at 260 nm for complexes 1 to 6 in a DNA:complex ratio of 4:1.    % of loss of LD signal at 260 nm after interaction with complexes DNA:Complex ratio 










































  The LD Titration for the Rh(III) triple stranded complex used the same conditions as used for CD titration of the same complex, using a less concentrated solution of ct‐DNA and complex due to precipitation at high concentration. An analogous experiment was carried  out  with  the  Fe(II)  triple  stranded  helicate  in  order  to  directly  compare  the binding  properties  of  both  complexes.  For  this,  the  Fe(II)  helicate  was  synthesized following the literature procedure;[4] synthetic details and characterization can be found in the experimental section 3.9.2.  The titration of 80 µM of ct‐DNA with increasing concentration of the Rh(III) complex, caused a dramatic coiling/bending effect on the DNA, with the band of the B‐DNA at 260 nm having an  intensity decrease of 62%  for 4:1  ratio DNA:complex  (Figure 3.30,  left). Once more, while  the  LD band of  the B‐DNA decreases  indicating  the  coiling/bending effect  of  the  complex on  ct‐DNA, no  ILD band  is observed  in  the  complex  region. This contrasts with the Fe(II) triple helicate which shows an ILD signal in the MLCT region of 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3.8 Gel Electrophoresis Studies   There  is  ongoing  interest  in  DNA  cleavage  effects  caused  by metal  complexes with multiple potential applications as structural probes and therapeutic agents.[12‐18] Many transition metal complexes that are able to cleave DNA have been reported and special attention has been given to rhodium diimine complexes because of their well known and interesting photocleavage properties.[15]  There are  several accepted oxidative mechanisms by which metal  complexes  target the nucleobases or the sugar functionality and cleave single and double stranded DNA. These mechanisms involve base oxidation by photosensitized singlet oxygen 1O2 and H‐atom abstraction from the sugar moiety (Figure 3.31). [19]      












The  cleavage  reactions  of  plasmid  DNA  can  be  monitored  using  agarose  gel electrophoresis.  Plasmid  DNA  can  assume  three  conformations:  the  supercoiled  (sc) which  is  an  intact  form  and migrates  faster  in  the  gel,  the  circular  conformation  (oc) which is obtained upon cuttng of one strand (nicking) of the sc form causing its opening to a relaxed circular structure that due to its conformation migrates slower; and finally, if  both  sc  strands  are  cleaved,  a  linear  (Lin)  form  will  appear  in  the  gel  and  it  will migrate  in  between  the  sc  and  the  oc  forms  (Figure  3.32).  Unwinding  angles  can  be quantified by applying the formula: 
 
φ= ­18 σ  / r(c) 




3.8.1 Gel electrophoresis Studies with Complexes (1­6)        In order to assess whether the complexes induced plasmid DNA unwinding and/or cleavage, agarose gel (1%) experiments were carried out with each of the complexes. Initial experiments were made using complexes 1 and 2 with plasmid DNA (pBR322). Plasmid solutions (100 µM) were incubated with different ratios of the complexes for a period  of  2  hours  at  37  °C.  In  order  to  confirm  the  stability  of  each  complex  at  this temperature, UV‐Vis  spectra were  carried out  for  a period of 2 hours under  the  same experimental conditions and no significant differences were registered. Table 3.4, shows the  ratios  of  plasmid  DNA:complex  which  were  used  in  the  gel  electrophoresis experiments. 
 
Table 3.4 Ratios of plasmid DNA (pBR322) and complex used in gel electrophoresis studies.   wells  c  1  2  3  4  5  6 DNA:Complex  DNA  20:1  12:1  8:1  6:1  5:1  3:1   The control plasmid DNA (lane c) contains a mixture of sc form in approximately 80% and oc  form in 20%. From Figure 3.33  it  is possible to observe that  in the presence of both  single  stranded di‐nuclear  complexes  (1  and 2)  the  sc  form  starts  to  run  slower from lane 1 with the complexes binding and causing unwinding of the supercoiled DNA. 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In addition, the presence of the complexes induces a decrease in the amount of sc form and the consequent increase of the nicked form (oc). This effect suggests that the complex binds and unwinds sc DNA and can induce single strand break to afford oc DNA. Both complexes have a very similar effect. The same experiment was carried out for the mononuclear  analogue    (complex 5)  and  after  two  hours  incubation  of  pBR322 with different  ratios  of 5  it  was  possible  to  observe  that  the  presence  of  the  complex  had almost no effect on the DNA (Figure 3.34). The differences of binding effect between the di‐nuclear  and  the  mononuclear  complexes  observed  by  these  gel  electrophoresis experiments  corroborate  what  was  already  seen  by  CD  and  LD  measurements,  with complex 5 showing much less binding to ct‐DNA.    
Rac ­Isomer 
Figure 3.33 Agarose gel (1%) electrophoresis showing the changes in the electrophoretic mobility of the  oc  and  sc  forms  of  pBR322 plasmid DNA  incubated  for  2  hours  at  37  °C with  different  ratios  of complex 1 (lane 1‐6) and complex 2 (lanes 7‐12). Lane c, pBR322 plasmid DNA in absence of complex (control‐c). 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To explore any coordinative binding effects, the complexes were incubated with the DNA  for 24 hours  instead of 2 hours. The ratios of DNA:complex were kept equal and experimental conditions used were the same. From Figure 3.35 is clear that the longer incubation time of 1 and 2 with plasmid DNA resulted in considerable higher cleavage effect  compared  with  the  incubation  for  2  hours  (Figure  3.33).  From  lanes  1  to  6  in Figure  3.35,  the  sc  band  disappears  straight  away  from  the  lowest  concentration  of complex used and the oc band increases. For complex 2, for the lowest concentration of complex (lane 7) the sc band could still be observed although with the slower mobility. On increasing the concentration of complex from lanes 8 to 11 this band was no longer observed.  The major  differences  between  this  experiment  and  the  2  hours  incubation experiment was the appearance of the new band with mobility between the sc and the oc forms, which was attributed to the linear form of plasmid DNA (lin). This band could easily be seen for complex 1 from lanes 1 to 5 and for complex 2 from lanes 8 to 11. The 
Figure 3.34 Agarose gel (1%) electrophoresis showing the changes in the electrophoretic mobility of the  oc  and  sc  forms  of  pBR322 plasmid DNA  incubated  for  2  hours  at  37  °C with  different  ratios  of complex 5 (lane 1‐6). Lane c, pBR322 plasmid DNA in absence of complex (control‐c). 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in a dark room (data shown in A.23). From the gel is possible to see that although some DNA  unwinding  is  observed  for  both  isomers  the  effect  is  much  less  than  when comparing  with  the  samples,  which  were  prepared  and  ran  in  the  gel  under  normal sunlight  conditions.  This  data  might  suggest  that  light  is  of  importance  for  the  DNA cleavage process to be more effective.  Complexes 3 and 4, were similarly incubated with pBR322 for 2 hours at 37 °C. The agarose  gel  (1%)  after  staining  (Figure  3.36)  shows  complex  4  to  cause  more  DNA unwinding with  the  increased mobility  of  the  sc  band  in  comparison with  complex 3.        Lane 12 shows disappearance of the sc form of the plasmid DNA and an increase of the amount of the oc form with slower mobility of the same band. The fact that complex 4 seems to affect the DNA more is consistent with CD and LD experiments. Comparing 3 and 4 with 1 and 2  reveals that complexes 1 and 2 exhibit a stronger DNA unwinding effect.                 




Complex 6  exhibits  a  similar  effect  to  complex 5, with  almost  no  effect  on  plasmid DNA (Figure 3.37); a slight retardation of the sc band is observed for the highest ratio DNA:complex (lane 6) as well as an small increase on the oc form. 
     The 24 hours incubation experiment using 3 and 4, revealed the complexes to cleave plasmid  DNA with  significant  differences  when  compared  with  the  same  experiment carried out only for 2 hours. Once more complex 4 has a greater effect. From lanes 1 to 6 and  7  to  12  (Figure  3.38)  it  is  possible  to  observe  the  nicking  of  the  DNA,  with  the amount of oc increasing when the concentration of the complex bound to plasmid DNA increases. Interestingly, it is suggested that complex 4, after 24 hours incubation is able to cleave both DNA strands with appearance of a linear form of DNA from lane 9, which is not evident for complex 3. The mononuclear analogue, complex 6, shows an increase on  the  unwinding  of  DNA  with  a  retardation  of  the  sc  band  more  marked  when compared with the 2 hours incubation with a consecutive increase of the oc form.  
Figure 3.37 Agarose gel (1%) electrophoresis showing the changes in the electrophoretic mobility of the  oc  and  sc  forms  of  pBR322 plasmid DNA  incubated  for  2  hours  at  37  °C with  different  ratios  of complex 6. Lane c, pBR322 plasmid DNA in absence of complex (control‐c). 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Figure 3.39 Agarose gel (1%) electrophoresis showing the changes in the electrophoretic mobility of the oc and sc forms of pBR322 plasmid DNA incubated for 2 hours at 37 °C (Top) with different ratios of complex 7 (lane 1‐6) and complex 8 (lanes 7‐12); (Bottom) pBR322 plasmid DNA incubated for 24 hours  at  37  °C    with  different  ratios  of  complex  7  (lane  1‐6)  and  complex  8  (lanes  7‐12);  Lane  c, pBR322 plasmid DNA in absence of complex (control‐c). 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Figure 3.40 Agarose gel (1%) electrophoresis showing the changes in the electrophoretic mobility of the  oc  and  sc  forms  of  pBR322 plasmid DNA  incubated  for  2  hours  at  37  °C with  different  ratios  of complex 10 (lane 1‐6); Lane c, pBR322 plasmid DNA in absence of complex (control‐c). 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Complexes 1 and 2 were incubated with four equivalents of nucleobase in 1 mM TAA buffer (pH 7.0) at 37 °C. An ESI‐MS spectrum of each complex  in  the presence of base was recorded at time 0, 2, 24 and 48 hours. ESI–MS confirm that adducts are formed for the two isomers after 24 hours of incubation at 37 °C. Both complexes showed the same behaviour  and  presented  the  same  adduct  patterns.  Similar  experiments  carried  out using  sodium  cacodylate  buffer  did  not  prove  effective,  perhaps  because  of  buffer interference with ESI. 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DNA  binding  studies  were  performed  by  CD  and  LD  spectroscopy  and  gel electrophoresis, using ct‐DNA and the Rh(III) complexes.  CD studies with 1 and 2 showed that both complexes bind to DNA with similar effect inducing a CD signal in the visible region (330 and 450 nm) although without affecting the  B‐DNA  conformation.  This  effect  is  much  reduced  when  comparing  with  the mononuclear analogue, complex 5, which does not induce any CD signal in the complex region  but  produces  minor  changes  in  the  DNA  absorbance  with  the  B‐DNA conformation  being  retained.  In  addition  CD  studies  with  poly[G‐C]  and  poly[A‐T] sequences  suggested  that  1  and  2  might  prefer  GC  rich  sequences  compared  to  AT, however the effect is less marked when compared with ct‐DNA. The LD spectra of 1 and 
2, show that both complexes are able to bend/coil ct‐DNA to similar extend. Positive ILD bands  in  the 300‐500 nm region  confirm  the binding of  the  complexes  to  ct‐DNA  in  a specific orientation and not randomly, and probably  to  the DNA major groove. The LD spectrum of 5, shows that the complex is still able to coil and bend ct‐DNA although to a lesser extent than 1 and 2.  MS  studies  made  with  DNA  mononucleotide  models  confirm  that  coordinative binding might occur after 24 hours incubation: complexes 1 and 2 with 5‐GMP showed peaks of base‐complex adducts. The  CD  spectra  of  complexes  3  and  4,  show  that  the  complexes  bind  to  ct‐DNA without affecting the B‐DNA conformation and showing ICD signals in the 311 and 439 nm region. The CD spectrum of  complex 6,  the mononuclear analogue,  shows  that  the complex  has  practically  no  affinity  towards  ct‐DNA,  with  the  DNA  absorbing  region 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almost not being affected and no appearance of an ICD signal in the visible region of the spectrum.  LD  studies  on  these  complexes  support  the  observations  made  by  CD spectroscopy, with  both  di‐nuclear  (3 and 4)  being  able  to  coil  and  bend  ct‐DNA  in  a specific orientation (confirmed by the ILD positive bands). On the other hand complex 6, in a similar way to 5, shows a small amount of DNA coiling and bending although in the LD spectra of 6 it is possible to observe a slight ILD signal suggesting that the interaction of the complex with the DNA occurs in a specific orientation. Complexes  1  and  2  exhibit  stronger  DNA  binding  affinities  by  CD  and  LD  when compared with 3  and 4 while  the mononuclear complexes 5 and 6 seem to have very similar effects between them.  Gel electrophoresis studies corroborated the results obtained with the spectroscopic methods. Complexes 1, 2, 3 and 4 are able to unwind and cleave plasmid DNA. 24 hours incubation experiment led to formation of linear DNA (double strand cleavage) although 
1 and 2 have stronger effect. Unwinding of plasmid DNA is much reduced for complexes 
5 and 6. CD and LD spectra of the di‐nuclear double stranded complexes (7 and 8) show that both  complexes  are  able  to  bind  strongly  to  ct‐DNA  causing  it  to  bend/coil  with  8 exhibiting a stronger effect than 7. Complex 7 has a very similar coiling/bending effect on  ct‐DNA, while 8  definitely  has  a  stronger  effect.  Both  di‐nuclear  complexes  (single and  double  stranded)  have  same  overall  charge  and  the  differences  observed  suggest that structure, together with different geometry of the complexes, is of high importance for  the  DNA  binding  affinities.  Also,  CD  studies  with  8  and  poly[G‐C]  and  poly[A‐T] suggested  that  the  complexes might  prefer  GC  but  once  again,  like with 1  and 2,  the interaction is less marked than with ct‐DNA. 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3.11.1 Materials  Ultrapure  water  (18.2  MX,  Fisher)  was  used  in  all  Circular  and  Linear  dichroism experiments,  electrophoresis gel and  for  the 5’‐GMP experiments. Poly[G‐C], Poly[A‐T] and  ct‐DNA  (highly  polymerised)  were  purchased  from  Sigma–Aldrich  and  were dissolved in water without any further purification. Stock solutions of the different DNA polymers were kept frozen until the day of use. The DNA concentrations of those stocks were  determined  by  UV–Vis  measurements  using  the  known  molar‐extinction coefficient of ε258 = 6600 mol‐1 dm3 cm‐1 per DNA base for ct‐DNA, ε258 = 6600 mol‐1 dm3 cm‐1 per DNA base for Poly[A‐T] and ε258 = 8400 mol‐1 dm3 cm‐1 per DNA base for Poly [G‐C]. Stock solutions of 1 M NaCl and 100 mM sodium cacodylate buffer (pH 6.8) were prepared and together with ct‐DNA stock, were used to obtain final solutions of ct‐DNA 300 µM, NaCl 20 mM and sodium cacodylate 1 mM. Commercially available Tris acetate–EDTA  (TAE,  from  Fisher) working  buffer was  used  for  gel  electrophoresis  of  pBR322 plasmid DNA purchased from New England Biolabs.  
 
3.11.2 CD Experiments For CD experiments, spectra were collected in cuvettes of 1 cm (750–200 nm region) pathlength,  using  a  Jasco  J‐715  spectropolarimeter.  Spectroscopic  titrations  were performed  from which CD  absorption  spectra were  recorded.  For  each  titration  three solutions were prepared: solution A of ct‐DNA (300 µM or 80 µM), NaCl  (20 mM) and sodium cacodylate buffer (10 mM); stock solution B of complex in water (500 µM or 170 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µM);  stock  solution  C  of  ct‐DNA  (600  µM  or  160µM),  NaCl  (40  mM)  and  sodium cacodylate buffer  (20 mM). First  solution A was  recorded  to have  the CD  spectrum of DNA without  complex. Then  the  titration was performed decreasing  the DNA:complex ratio from 60:1 to 4:1 by adding aliquots of solution B. For each volume of solution B, the same volume of solution C was added to ensure that the concentration of ct‐DNA, NaCl and sodium cacodylate remained unaltered.  
 
3.11.3 Flow LD Experiments Flow LD spectra were collected using a flow Couette cell (Krometek) in a Jasco J‐715 spectropolarimeter adapted for LD measurements. Long molecules, such as DNA can be orientated  in a  flow Couette cell. The  flow cell  consists of a  fixed outer cylinder and a rotating  solid  quartz  inner  cylinder,  separated  by  a  gap  of  0.5  mm,  giving  a  total pathlength of 1 mm. The titration was identical to that described for the CD experiment.  
 
3.11.4 Gel Electrophoresis Experiments 
 The electrophoresis experiments were carried out using gel  trays of 210 x 150 mm with a 15‐toothed comb to produce the sample wells. An Electrophoresis Power Supply‐EPS 301 system was used as a constant voltage supply set to 120 V and 300 mA. The gel was prepared by warming up 2 g of agarose (from USB Corporation) in 1x Tris acetate buffer  (1xTAE,  which  was  obtained  by  dilution  of  100  ml  of  10  x  TAE,  supplied  by SIGMA,  in  1  L  of water).  The  same 1  x TEA buffer was  used  as  a working  buffer.  The solutions  to  analyze were prepared  in a  volume of 16 µl  containing: 96.3 µM pBR322 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ESI‐MS  Nucleotide  binding  studies:  5’‐GMP  and  9EG  were  purchased  for  Sigma‐Aldrich,  stored  at  4°C  in  a  dessicator  and  used without  any  further  purification.  They were dissolved in 1 mM TAA buffer (pH 7.0) before each experiment. Fresh solutions of complexes  in 1 mM TAA buffer  (pH 7.0) were used. The stock solution of base was (4 mM)  and  of  complex  (0.5  mM).  The  solutions  were  mixed  to  have  a  final  ratio base:complex  of  4:1  in  a  final  volume  of  100 µl.  The  solutions were  incubated  for  48 hours at 37 °C in the dark.   ESI‐MS spectra were taken of freshly prepared mixtures of base  plus  complex  and  after  2,  24,  48  hours.  The  optimal  ESI  (+)  conditions  for observing  the peaks of  the complexes and complex plus base were  found to be a cone voltage of 10 eV using methanol as a spray solvent.                                                         † ImageJ Software, National Institutes of Health, USA. 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3.11.6 Synthesis of the Fe (II) Triple Helicate [Fe2(Lim)3](PF6)4[22]   The  Lim  and  the  racemic  and  [Fe2(Lim)3](PF6)4  were  synthesized  according  to literature procedures.[22] Three equivalents of Lim and 2 equivalents of iron (II) chloride were heated under reflux in methanol for 2 hours. The resulting purple colored solution was  cooled  to  room  temperature  and  the  respective  PF6  salt  of  the  complex  was  re‐precipitated  from  a  saturated  methanolic  NH4PF6  solution.  The  purple  precipitate  of  [Fe2(Lim)3](PF6)4 was isolated by filtration and abundantly washed with methanol.        
 
Figure 3.41‐ Chemical structure of Lim.  Positive‐ion  ESI  (30  eV,  CH3CN):  m/z  (%)  311  [Fe2(Lim)3]4+(100),  421 [Fe2(Lim)3F]3+(10), 462 [Fe2(Lim)3(PF6)]3+ (20). 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4.1 Introduction As discussed previously in chapter 1 the parent cylinders with Fe(II) and Ru(II) metal centers both exhibited cytotoxic activity in different cancer cell lines. The iron cylinder shows activity comparable with carboplatin and further biological tests showed that it is not  mutagenic  or  genotoxic,  which  represents  a  big  advantage  over  cisplatin.  More exciting is the cytotoxicity exhibited by the dinuclear double stranded Ru(II) complexes synthesized by Hotze  that  showed  activity  comparable  to  cisplatin  in  both  breast  and ovarian  cancer  cell  lines  with  some  isomers  exhibiting  activity  ten  times  higher  than cisplatin.  The  fact  that  these  dinuclear  unsaturated  helicates  exhibited  higher  activity than  the  saturated  triple  helicates  corroborates  the  design  concept  that  incorporating coordinative DNA binding as well as the cylinder architectures might lead to enhanced biological activity. For this reason it was pertinent to investigate and evaluate the cellular activity of the newly synthesized rhodium (III) complexes. For these studies, two different cancer cell lines were  chosen, MDA‐MB‐231  (breast)  and A2780  (ovarian),  and MTT assays were carried out to measure the IC50 values for each complex. 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These  biological  studies  were  made  in  a  direct  collaboration  with  Victoria Sadovnikova and Laura Rowley  from the Hannon Group and all  the experiments were performed in the School of Biosciences of University of Birmingham†.  
 
4.2 Cytotoxic activity by MTT Assay 























Cell  growth  and  details  of  the  incubation  of  the  complexes  with  each  cell  line  are described in the experimental section (4.6.2 and 4.6.3). IC50 values were calculated by a colorimetric  test, MTT  assay.[1]  The MTT  yellow  reagent  (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium  bromide)  is  reduced  to  purple  formazan  by  the mitochondrial reductase in the living cells (Scheme 4.1).      
 
 
Scheme 4.1 Reduction of the MTT reagent to formazan by the mitochondrial reductase in living cells.  Upon treatment of each cell line with the complexes, MTT reagent is added and upon 2  hours  of  incubation,  UV‐Vis  detection  measures  the  quantity  of  formazan  formed which is proportional to the amount of living cells after treatment with the complexes.  





























































     The  most  surprising  result  is  the  cytotoxic  activity  observed  for  complex  5,  the mononuclear analogue of 1 and 2. This complex shows a very similar activity in both cell lines tested with activity equivalent to cisplatin. These results are somewhat unexpected as  the DNA binding studies of  this  complex using CD and LD  (chapter 3,  section 3.4.1, 3.7.1)  showed  that  the  complex almost did not have  a  significant  effect  on DNA when compared with the dinuclear analogues. In addition, gel electrophoresis studies showed that 5  did  not  cause  as much  plasmid  DNA  unwinding  as 1  and 2  (chapter  3  section 3.8.1).  This may  suggest  that  this  complex  has  a  different mode  of  action  to  cisplatin, perhaps with DNA not the only biological target. In fact, recent reports show that DNA may  indeed not be  the only  target  for  several metal  complexes and  that other cellular targets and modes of actions may be responsible for biological activity of some Rh(III) organometallic complexes.[2, 3] 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It is possible that the smaller size and charge (1+) of this complex, in comparison with the dinuclear analogues, may allow the complex to be more readily taken up into cells than the rac and meso dinuclear isomers with 2+ charge. Nevertheless this would require further  investigations  to  confirm  it. Recent  reports  from Farrell  and  co‐workers  show that  increasing  the  charge  can  enhance  the  cellular  accumulation  and  thereby cytotoxicity  in some systems.[4] Reports from Hannon and co‐workers showed that the 4+  dinuclear  single  stranded  complex  [Ru2(Lim)(bpy)4]4+  is  inactive  against    several different  cancer  cell  lines  tested  while  the  parent  cylinder  [Ru2(Lim)3]4+  (similar  size, same charge) is active against A2780 and T47D with IC50 of 72 and 53 µM respectively.[5]  
 
Table 4.1 IC50 (µM) values for complexes 1 and 2, 5, 6 and cisplatin.              



































































Figure 4.6 Principle of the Polymerase chain reaction (PCR) amplification scheme, representation of the first cycle.  After demonstrating by CD, LD and gel electrophoresis techniques that complexes 7 and  8  are  able  to  bind  to  DNA  and  cleave  plasmid  DNA,  we  decided  to  investigate whether these interactions could prevent DNA transactions in vitro. PCR reactions were performed using a plasmid pUC19 as substrate and two specific primers together with a Taq DNA polymerase and the four natural deoxynucleotides (A, T, C, G), plus increasing concentrations of complexes 7 and 8. Agarose gel electrophoresis of  the PCR products 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The  cytotoxicity  of  the  new  dinuclear  Rh(III)  single  and  double  stranded complexes 1 and 2, 7 and 8 and the mononuclear analogues 5 and 6 was evaluated. All complexes  were  tested  for  their  water  stability  for  a  period  of  72  hours  showing  no degradation for this period at 37 °C. IC50 values were determined by an MTT assay and complexes 1 and 2 were found to be active against MDA‐MB‐231 breast cancer cell lines although with less cytotoxicity than  cisplatin.  When  tested  against  ovarian  cancer  cell  lines  these  complexes  were shown to be  inactive. On the contrary, complex 5,  the mononuclear analogue,  is active against  the  breast  and  ovarian  cancer  cell  lines  tested  with  activity  comparable  to cisplatin. This result was very interesting since the complex showed no significant effect on ct‐DNA plus, the similar complex 6 (mononuclear with bpy) is inactive towards both cell lines with IC50 values over 100 µM. To further investigate and better understand the biological  activity  of  these  complexes,  assays  to  determine  the  IC50  value  of  these complexes  in  a  different  cell  line  are  ongoing  together  with  the  first  studies  of  the cytotoxicity of complexes 3 and 4 (dinuclear Rh(III) single stranded with bpy).  Preliminary  IC50 values  for  the double stranded Rh(III) complexes 7  and 8,  show that the complexes are inactive with values close to or over 100 µM. These results were unexpected given the significant effect of these complexes on ct‐DNA. Nevertheless PCR studies  showed  that  these  complexes  are  able  to  inhibit  and  block  the  PCR  DNA replication  in  vitro with exciting  results  comparable with  the  recent data obtained  for the Ru(II) cylinder.  These  results  should  encourage  further  studies  about  biological  activity  of  these 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MDA‐MB‐231  and  A2780  cell  lines were  obtained  from  the  European  Collection  of Cell  Cultures  (ECACC),  a  Health  Protection  Agency  Culture  Collection.  Dulbecco`s modified  Eagle  medium  (DMEM)  and  fetal  bovine  serum  (FBS)  were  obtained  from Invitrogen, UK. Antibiotic antimycotic solution, L‐glutamine, trypsin‐EDTA, hepes buffer solution, phosphate buffered saline (PBS), MTT (MTT = 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium  bromide),  dimethyl  sulfoxide  (DMSO)  were  purchased  from Sigma‐Aldrich,  UK.  Tissue  culture  flasks,  96  well  flat‐bottomed  microtiter  plates (Corning Costar) were obtained from Appleton Woods, UK. 
4.6.2 Cell Growth Conditions 
MDA‐MB‐231 human breast cancer and A2780 human ovarian cancer cell lines were grown as monolayers in DMEM medium supplemented with 10% FBS, 1% L‐glutamine, 1% Hepes buffer, 1% sodium pyruvate and 1% of antibiotic antimycotic solution. Cells were  maintained  in  the  incubator  at  37  °C,  5%  CO2  in  a  humidified  atmosphere  and regularly checked for absence of contamination. 
4.6.3 MTT Assay[1] 
Cells  were  collected  from  the  tissue  culture  flasks  using  1%  trypsin‐PBS  solution. Single cell suspensions were prepared; cells counted using hemocytometer and placed in 96 well microtiter plates at density of 8.000 cells/well and total volume 100 μl/well. Plates with cells were incubated for 24 hours to allow cells to attach to the surface. The 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cells were then treated with 5 different concentrations (100 μM, 50 μM, 25 μM, 12.5 μM, 6.25  μM)  of  synthesized  compounds  dissolved  in  fresh  mediums  and  incubated  for further  72  hours.  After  72  hours  of  incubation  20  μl  of  a  5  mg/ml  MTT  solution  in phosphate buffer saline was added to each well of the 96 well plates except three wells of the control and cells were incubated for 2 hours. The medium was carefully removed and 200 μl of DMSO was added to each well of the plate to dissolve the formed purple crystals of formazan. The absorbance was measured 15‐20 minutes after the addition of DMSO using a 96‐well plate reader (BioRad) at 590 nm. 
4.6.4 PCR Experiments 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5.1 Conclusions The  work  described  in  this  thesis  aimed  to  create  and  study  new  DNA‐binding Rhodium  Supramolecular  complexes.  A  key  first  aim  was  therefore  to  design  and investigate  synthetic  procedures  for  the  synthesis  of  new  Rh(III)  supramolecular complexes.  This  target was  successfully  achieved  and  Chapter  2  shows  the  synthesis, purification  and  characterization  of  new  Rh(III)  mononuclear  and  dinuclear  single, double and triple stranded complexes. In  the  case  of  the  dinuclear  Rh(III)  double  and  triple  stranded  supramolecular helicates they are the first examples known to date. The Lazo was the ligand of choice for the Rh(III) dinuclear complexes since most probably due to its  lack of stability, Lim did not produce the complexes designed. Comparing with the Ru(II) chemistry,  the double stranded complexes are more difficult  to prepare:  for Ru(II), 5 different  isomers were identified  and  isolated, while  for  Rh(III)  only  two  isomers were  separated  (rac  and  a 
meso ββ isomers), although in similar yields to the Ru(II) analogues. The Ru(II) ones, are neutral  complexes while  the  Rh(III)  are  cationic which makes much more  difficult  to separate them as a consequence.  For  the  dinuclear  Rh(III)  triple  stranded  complex,  much  has  been  achieved.  This 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complex  is  obtained  rapidly  from  crude  reaction  in  higher  yield  and  purity  when compared with  the  Ru(II)  analogue.  Comparing with  the  Ru(II)  this  complex  is much easier  to  make.  But  is  harder  to  isolate  pure  since,  again  the  higher  charge  of  the complex perhaps makes the purification process much more difficult. Again, this  is the first  Rh(III)  triple  stranded  supramolecular  complex  and  further  investigations  and characterization on this complex are  required.  In Chapter 3, the DNA binding properties of the complexes were evaluated by CD, LD, UV‐Vis spectroscopy using ct‐DNA and gel electrophoresis with plasmid DNA. From these data it was possible to conclude that all dinuclear complexes bind to DNA with CD studies  for  complexes  1,  2,  3,  4,  7,  8  and  10  exhibiting  an  ICD  signal  in  the  metal complex region proving that they bind to ct‐DNA, and they do it so without affecting the overall B‐DNA structure. By contrast, mononuclear complexes 5 and 6 showed nearly no effect  towards ct‐DNA. Also, LD experiments showed that  the dinuclear complexes are effective DNA bending/coiling agents when compared with the mononuclear analogues. The similar size and structure of the dinuclear complexes to the Fe(II) and Ru(II) cylinders  suggest  that  they might bind  to DNA  in  the major groove.  Studies with DNA bases  and  complexes  1  and  2,  confirmed  that  coordinative  binding  might  also  be  an additional binding mode. Gel  electrophoresis  studies  showed  that  the  single  stranded  complexes  are effective  plasmid  DNA  unwinding  and  cleaving  agents  while  the  double  stranded complexes  seem  to  directly  cause  DNA  cleavage.  Thus  it  is  demonstrated  that incorporation of rhodium into the supramolecular structures does lead to DNA artificial nuclease activity as hoped at the outset of the work. This is therefore an additional to the tool  box  available  and  complements  the  copper(I)  double  stranded  supramolecular 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compounds that were previously shown to cut DNA. Also, by incorporating the metal complex units  into the supramolecular structure leads to more dramatic DNA binding than the mononuclear analogues. In  Chapter  4,  the  biological  activity  of  some  of  the  complexes  synthesized  was explored.  The  single  stranded  dinuclear  Rh(III)  complexes with  phen  ligands  showed cytotoxic  activity  against  MDA‐MB‐231  breast  cancer  cell  lines  but  were  inactive towards  the ovarian  cell  line  tested  (A2780). When  the mononuclear  complexes were tested, surprisingly,  the complex with phen ligand was active with activity comparable to cisplatin in both cell lines while the one with bpy ligand is non‐active.  The IC50 values for the double stranded complexes (7 and 8) are not as dramatic as those  of  the  corresponding  ruthenium double  stranded ones  (some of which  are  very active indeed) although the cell line tested was different. 
 
5.2 Future work In  this work  the  synthesis  of  new different  supramolecular  Rh(III)  complexes with the dinucleating ligand developed by the Hannon group was achieved for the first time. Although  the  procedures  established  allowed  the  synthesis  of  the  complexes,  for example  the yields obtained  for  the double  stranded  isomers  are  fairly  low. Due  their exciting DNA binding features studied in Chapter 3 and to further study their biological activity,  improvement  of  the  synthetic  procedure  and  access  to  quantities  of  these materials  would  certainly  prove  useful.  For  instance,  microwave  assisted  synthesis under the similar reaction conditions (propanol:water 2:1) might avoid formation of co‐contaminant  polymeric  material.  Microwave  radiation  often  overcomes  the  kinetic inertness of compounds and simplifies the replacement of ligands in the initial complex 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The  ESI‐MS  exhibited  a  doubly  charged  peak  with  m/z  =  481  corresponding  to  the species  [Rh2(Lazo)2]2+.  The  1H‐NMR  in  CD3CN  showed  a  mixture  of  several  isomeric species with the aromatic region showing overlapping peaks. Several attempts to purify this complex using flash chromatography failed. As future work on this complex, HPLC purification/separation  should be attempted using  the method  (or  slightly  changing  it according  with  the  first  separation  profile)  developed  for  the  analogous  complexes described in this thesis.  In the chapter 3, CD studies with the single stranded complexes 1 and 2 and with the double  stranded 8,  showed  that  they might  preferentially  bind  to  G‐C  than  A‐T  sites. Although preliminary, these results are quite interesting and they should be considered as a subject for future studies. DNA footprinting has been a methodology widely used to explore  the  selectivity  of  several  metal  complexes,  in  particularly  much  of  the  work explored  in  chapter  one  done  by  Barton  as  co‐workers  has  been  on  Rh(III)  diimine complexes  and  their  different  DNA  selectivity.[7]  Taking  into  consideration  that  gel electrophoresis  studies  presented  herein  for  the  single  and  double  stranded  Rh(III) 
Chapter 5­Conclusions and Future Work  
  227 
complexes  showed  that  all  complexes  are  able  to  cleave plasmid DNA  (pBR322), DNA 
footprinting studies would be of importance to localize the DNA cleavage site. Also, the results  obtained  with  plasmid  DNA  and  the  complexes  presented  herein  should encourage  future  photocleavage  studies  to  evaluate  the  DNA  damage  caused  by  the compounds.  Coordinative binding of the complexes to DNA should be further investigated. UV‐Vis, CD  and  LD  studies  with  ct‐DNA  and  the  complexes  changing  the  experimental conditions, like buffer (without presence of Cl ions which may difficult the coordinative binding to DNA) and incubated samples over a period of 24 hours at 37 °C may provide further  information  about  structural  changes  of  the  B‐DNA  after  interaction with  the complexes.  An  experiment  run  with  a  single  stranded  isomer  by  LD  showed  a  more intense  coiling/bending  of  ct‐DNA  upon  incubation  suggesting  an  additional  DNA binding mode  (coordinative binding) to the major groove binding.  In  chapter  4,  the  biological  activity  of  some  of  the  complexes  synthesized  was evaluated. Tests with a different ovarian cancer cell  line (SKOV‐3) for these complexes are  ongoing  to  try  to  understand  if  the  complexes  have  some  kind  of  specificity  for breast over ovarian cancer. In addition to understand more deeply why the mononuclear complex 5 has such a different behaviour in cancer cell lines comparing with 6, cellular uptake studies are of interest.  Inductively  coupled  plasma  mass  spectrometry  (ICP‐MS)  and  atomic absorption  spectroscopy  (AAS)  are  techniques  commonly  used  to  explore  the  cellular uptake of several complexes.[8] Certainly this would allow to further understanding the 
Chapter 5­Conclusions and Future Work  
  228 
mode of action of these two compounds. This technique would be useful as well to study the new  isomers of Rh(III) double  stranded  complexes. Preliminary  tests  showed  that the two isomers have very high IC50 values with complex 7 being non‐active in MDA‐MB‐231 cancer cell. Another interesting feature to explore would be to test the complexes in the same cancer cell lines with the use of irradiation. It is known in the literature that for example  [Rh(phen)2Cl2]+  shows  antitumor  properties  when  irradiated  with  light  of  a certain wavelength and also that it shows a minimal association with DNA in the dark.[9, 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 cis‐[Rh(Lazpy)(phen)Cl2](PF6) (5)  cis‐[Rh(Lazpy)(phen)Cl2](PF6) Polymorph of (5)  Empirical Formula  C23H17Cl2N5Rh, PF6  C23H17Cl2N5Rh, PF6 
Mr  682.20  682.20 







V [Å3]  2515.46(18)  9865.2(4) Z,  Z’  4, 1  16, 2 
ρcalcd (Mg/m3)  1.801  1.837 
























































































































































































































































































































































































































































































































A.23‐ Electrophoresis Gel of complexes 1 and 2 under dark conditions.                Agarose  gel  (1%)  electrophoresis  showing  the  changes  in  the  electrophoretic mobility  of  the  oc  and  sc forms of pBR322 plasmid DNA incubated for 2 hours at 37 °C under dark conditions with different ratios of complex 1 and complex 2. Lane c, pBR322 plasmid DNA in absence of complex (control‐c). 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A.24­ ESI‐MS of complex 1, 0 hours after incubation at 37 °C with 5‐GMP (fresh). 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A.25­ ESI‐MS of complex 1, 24 hours after incubation at 37 °C with 5‐GMP. 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A.26­ ESI‐MS of complex 2, 0 hours after incubation at 37 °C with 5‐GMP (fresh). 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A.27­ ESI‐MS of complex 2, 24 hours after incubation at 37 °C with 5‐GMP.   
  
